LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. (“Vanda” or “the Company”) (NASDAQ: VNDA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Aurelius Value published a report on February 11, 2019, which details a whistleblower lawsuit against Vanda. The Lawsuit alleges that “Vanda has engaged in a series of fraudulent schemes, some personally orchestrated by [its CEO], to defraud government payors.” The whistleblower states that these schemes involve “illegal off-label promotion of both of Vanda’s drugs, Vanda’s participation in a fraud involving doctors writing hundreds of ‘fake prescriptions’ and pocketing cash using Vanda-issued copay cards, falsified documents in internal systems, and resignations of senior executives who refused to participate in illegal activity.” Based on this report, Vanda’s share price dropped significantly the same day.

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at  www.schallfirm.com , or by email at  brian@schallfirm.com .

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm Brian Schall, Esq.  Sherin Mahdavian, Esq. 310-301-3335 Cell: 424-303-1964 info@schallfirm.com

www.schallfirm.com

SOURCE:

The Schall Law Firm